Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Consolidated Net Income: 2024-2025

Historic Consolidated Net Income for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -$74.1 million.

  • Kura Oncology's Consolidated Net Income fell 36.23% to -$74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$214.9 million, marking a year-over-year change of. This contributed to the annual value of -$174.0 million for FY2024, which is 13.99% down from last year.
  • As of Q3 2025, Kura Oncology's Consolidated Net Income stood at -$74.1 million, which was down 12.09% from -$66.1 million recorded in Q2 2025.
  • Kura Oncology's Consolidated Net Income's 5-year high stood at -$17.2 million during Q4 2024, with a 5-year trough of -$74.1 million in Q3 2025.
  • Its 2-year average for Consolidated Net Income is -$52.8 million, with a median of -$54.4 million in 2024.
  • Data for Kura Oncology's Consolidated Net Income shows a maximum YoY tumbled of 36.23% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Kura Oncology's Consolidated Net Income stood at -$17.2 million in 2024, then plummeted by 36.23% to -$74.1 million in 2025.
  • Its last three reported values are -$74.1 million in Q3 2025, -$66.1 million for Q2 2025, and -$57.4 million during Q1 2025.